Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,885.00
+45.00 (1.17%)
Last updated: Sep 1, 2026, 1:19 PM KST

Yuyu Pharma Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
20,98729,09141,83230,60525,83950,263
Trading Asset Securities
6,8783,614817.271,7494,939-
Cash & Short-Term Investments
27,86532,70542,65032,35430,77850,263
Cash Growth
-3.18%-23.32%31.82%5.12%-38.77%145.15%
Accounts Receivable
17,06418,55317,66220,80121,94019,528
Other Receivables
370.241,3292,0693,6532,8763,265
Receivables
17,43419,88219,73124,45524,81622,793
Inventory
43,18042,22138,62844,15239,83225,225
Prepaid Expenses
494.44940.94327.71341.03238.84115.08
Other Current Assets
2,4501,166611.32294.62692.94491.06
Total Current Assets
91,42496,914101,947101,59796,35898,888
Property, Plant & Equipment
100,06493,45789,98781,40381,37180,341
Long-Term Investments
10,37610,2178,6266,8675,9445,712
Goodwill
153.77153.77153.77503.2250.8350.83
Other Intangible Assets
2,3812,6802,9773,7643,6664,087
Long-Term Accounts Receivable
----0493.76345.28
Long-Term Deferred Tax Assets
1,1051,028909.48---
Other Long-Term Assets
2,2802,6732,9884,0796,8263,561
Total Assets
207,884207,223207,687198,214195,205192,985

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9,1119,3779,47510,95215,8418,982
Accrued Expenses
1,4491,4161,4941,5041,6131,553
Short-Term Debt
22,16227,19131,18624,48236,1648,200
Current Portion of Long-Term Debt
16.6633.321,475448.73718.281,812
Current Portion of Leases
473.34441.66581.1455.55542.86414.94
Current Income Taxes Payable
1,000780.61,043574.8297.04219.32
Other Current Liabilities
14,10019,70819,22611,5589,1408,832
Total Current Liabilities
48,31358,94864,48049,97564,31630,015
Long-Term Debt
5,000-33.3213,6401,60028,456
Long-Term Leases
403.65256.52369.17380.92250.96282.81
Pension & Post-Retirement Benefits
3,3923,1032,8592,2861,7322,491
Long-Term Deferred Tax Liabilities
3,8083,5814,0944,3603,6902,897
Other Long-Term Liabilities
787.16791.74788.347,215242.12158.07
Total Liabilities
61,70366,67972,62477,85871,83164,300

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
20,20217,60917,60917,60917,60917,609
Additional Paid-In Capital
64,54064,68464,98165,07558,80358,803
Retained Earnings
29,64632,49825,78920,17131,39636,540
Treasury Stock
--7,788-5,791-5,791-6,156-4,371
Comprehensive Income & Other
20,40720,03620,05012,53112,57213,107
Total Common Equity
134,794127,039122,639109,595114,224121,689
Minority Interest
11,38710,9139,8318,1686,5584,404
Shareholders' Equity
146,181140,544135,063120,356123,374128,685
Total Liabilities & Equity
207,884207,223207,687198,214195,205192,985

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
28,05627,92333,64439,40739,27639,166
Net Cash (Debt)
-191.174,7839,005-7,053-8,49911,097
Net Cash Growth
--46.89%---1907.08%
Net Cash Per Share
-9.48237.87529.76-433.55-512.57695.34
Filing Date Shares Outstanding
16.5215.7516.1816.1816.3516.66
Total Common Shares Outstanding
16.5215.7516.1816.1816.3516.66
Working Capital
43,11137,96737,46851,62132,04268,873
Book Value Per Share
8159.778067.267578.446772.386985.777306.09
Tangible Book Value
132,260124,205119,509105,327110,506117,551
Tangible Book Value Per Share
8006.357887.287384.996508.666758.427057.65
Land
39,96239,96239,96230,38030,38030,380
Buildings
54,57954,56153,19253,39752,13848,966
Machinery
45,78344,57842,21739,22937,06733,334
Construction In Progress
11,1403,686385.8259.361,3333,454